Socioeconomic differences in healthy and disease-free life expectancy between ages 50 and 75: a multi-cohort study.


Journal

European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966

Informations de publication

Date de publication:
01 04 2019
Historique:
pubmed: 12 10 2018
medline: 14 8 2019
entrez: 12 10 2018
Statut: ppublish

Résumé

There are striking socioeconomic differences in life expectancy, but less is known about inequalities in healthy life expectancy and disease-free life expectancy. We estimated socioeconomic differences in health expectancies in four studies in England, Finland, France and Sweden. We estimated socioeconomic differences in health expectancies using data drawn from repeated waves of the four cohorts for two indicators: (i) self-rated health and (ii) chronic diseases (cardiovascular, cancer, respiratory and diabetes). Socioeconomic position was measured by occupational position. Multistate life table models were used to estimate healthy and chronic disease-free life expectancy from ages 50 to 75. In all cohorts, we found inequalities in healthy life expectancy according to socioeconomic position. In England, both women and men in the higher positions could expect 82-83% of their life between ages 50 and 75 to be in good health compared to 68% for those in lower positions. The figures were 75% compared to 47-50% for Finland; 85-87% compared to 77-79% for France and 80-83% compared to 72-75% for Sweden. Those in higher occupational positions could expect more years in good health (2.1-6.8 years) and without chronic diseases (0.5-2.3 years) from ages 50 to 75. There are inequalities in healthy life expectancy between ages 50 and 75 according to occupational position. These results suggest that reducing socioeconomic inequalities would make an important contribution to extending healthy life expectancy and disease-free life expectancy.

Sections du résumé

BACKGROUND
There are striking socioeconomic differences in life expectancy, but less is known about inequalities in healthy life expectancy and disease-free life expectancy. We estimated socioeconomic differences in health expectancies in four studies in England, Finland, France and Sweden.
METHODS
We estimated socioeconomic differences in health expectancies using data drawn from repeated waves of the four cohorts for two indicators: (i) self-rated health and (ii) chronic diseases (cardiovascular, cancer, respiratory and diabetes). Socioeconomic position was measured by occupational position. Multistate life table models were used to estimate healthy and chronic disease-free life expectancy from ages 50 to 75.
RESULTS
In all cohorts, we found inequalities in healthy life expectancy according to socioeconomic position. In England, both women and men in the higher positions could expect 82-83% of their life between ages 50 and 75 to be in good health compared to 68% for those in lower positions. The figures were 75% compared to 47-50% for Finland; 85-87% compared to 77-79% for France and 80-83% compared to 72-75% for Sweden. Those in higher occupational positions could expect more years in good health (2.1-6.8 years) and without chronic diseases (0.5-2.3 years) from ages 50 to 75.
CONCLUSION
There are inequalities in healthy life expectancy between ages 50 and 75 according to occupational position. These results suggest that reducing socioeconomic inequalities would make an important contribution to extending healthy life expectancy and disease-free life expectancy.

Identifiants

pubmed: 30307554
pii: 5126423
doi: 10.1093/eurpub/cky215
pmc: PMC6426044
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

267-272

Subventions

Organisme : Medical Research Council
ID : MR/K013351/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R024227/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of the European Public Health Association.

Références

Soc Sci Med. 2001 Jun;52(11):1629-41
pubmed: 11327137
Am J Epidemiol. 2001 Aug 15;154(4):373-84
pubmed: 11495861
J Gerontol A Biol Sci Med Sci. 2004 Jun;59(6):M590-7
pubmed: 15215269
J Epidemiol Community Health. 2006 Jan;60(1):7-12
pubmed: 16361448
Soc Sci Med. 2006 May;62(10):2489-99
pubmed: 16364526
J Epidemiol Community Health. 2006 Nov;60(11):937-44
pubmed: 17053282
Int J Epidemiol. 2007 Feb;36(1):32-9
pubmed: 17101614
Scand J Public Health. 2008 Sep;36(7):737-43
pubmed: 18684778
J Aging Soc Policy. 2009 Jan-Mar;21(1):75-93
pubmed: 19197609
Demography. 2009 Aug;46(3):627-46
pubmed: 19771948
Lancet. 2009 Dec 5;374(9705):1889-96
pubmed: 19897238
Demogr Res. 2010 Jan 26;22(6):129-158
pubmed: 20463842
J Epidemiol Community Health. 2011 Nov;65(11):972-9
pubmed: 21106546
J Gerontol B Psychol Sci Soc Sci. 2012 May;67(3):343-53
pubmed: 22421807
Health Serv Res. 2013 Feb;48(1):218-35
pubmed: 22670874
Int J Epidemiol. 2013 Dec;42(6):1640-8
pubmed: 23143611
J Aging Health. 2013 Aug;25(5):815-38
pubmed: 23781016
Soc Sci Med. 2013 Oct;94:1-8
pubmed: 23931939
Longit Life Course Stud. 2011;2(2):null
pubmed: 24376472
PLoS One. 2015 Jun 26;10(6):e0130747
pubmed: 26115099
Lancet. 2016 Feb 20;387(10020):779-86
pubmed: 26680218
Int J Epidemiol. 2016 Aug;45(4):1260-1270
pubmed: 27488415
J Aging Health. 2016 Oct;28(7):1256-78
pubmed: 27590801
Int J Epidemiol. 2018 Jan 10;:null
pubmed: 29340637

Auteurs

Jenny Head (J)

Department of Epidemiology and Public Health, University College London, London, UK.

Holendro Singh Chungkham (HS)

North-East Centre, Indian Statistical Institute, Tezpur, India.

Martin Hyde (M)

Centre for Innovative Ageing, University of Swansea, Swansea, UK.

Paola Zaninotto (P)

Department of Epidemiology and Public Health, University College London, London, UK.

Kristina Alexanderson (K)

Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Sari Stenholm (S)

Department of Public Health, University of Turku and University Hospital Turku, Turku, Finland.
School of Health Sciences, University of Tampere, Tampere, Finland.

Paula Salo (P)

Department of Psychology, University of Turku, Turku, Finland.
Finnish Institute of Occupational Health, Turku, Finland.

Mika Kivimäki (M)

Department of Epidemiology and Public Health, University College London, London, UK.
Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Marcel Goldberg (M)

Inserm, Population-based Cohorts Unit-UMS 011, Villejuif, France.

Marie Zins (M)

Inserm, Population-based Cohorts Unit-UMS 011, Villejuif, France.

Jussi Vahtera (J)

Department of Public Health, University of Turku and University Hospital Turku, Turku, Finland.

Hugo Westerlund (H)

Stress Research Institute, Stockholm University, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH